CUE

Cue Biopharma (CUE)

About Cue Biopharma (CUE)

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Details

Daily high

$34.60

Daily low

$31.16

Price at open

$31.89

52 Week High

$45.50

52 Week Low

$4.97

Market cap

143.7M

Dividend yield

Volume

157,322

Avg. volume

197,386

P/E ratio

-6.19

Cue Biopharma News